- 1. 1-(11-Dodecylamino-10-Hydroxyundecyl)-3,7-Dimethylxanthine
- (UMLS (NCI) C0539090) =Organic Chemical; Pharmacologic Substance ;
| - 51. Docetaxel/Methotrexate
- (UMLS (NCI) C0879466) =Therapeutic or Preventive Procedure ;
|
- 2. 1D1O Anti-lymphoma Antibody
- [A type of monoclonal antibody that is being studied as a treatment for hematologic (blood) cancers. ( NCI )] (UMLS (NCI) C1122758) Apolizumab =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 52. Docetaxel/Mitoxantrone
- (UMLS (NCI) C0879303) =Therapeutic or Preventive Procedure
|
- 3. DO
- [A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti. (NCI) ( NCI )] (UMLS (NCI) C0013014) =Geographic Area
| - 53. Docetaxel/MS-209
- (UMLS (NCI) C0879435) =Therapeutic or Preventive Procedure
|
- 4. Do at bedside or portable (may be used with other codes)
- (UMLS (HL7) C1549560) =Idea or Concept =Processing priority;
| - 54. Docetaxel/Oblimersen
- (UMLS (NCI) C0935709) =Therapeutic or Preventive Procedure
|
- 5. Do NOT inform patient
- (UMLS (HL7) C1549023) =Intellectual Product =Inform person code;
| - 55. Docetaxel/Oxaliplatin
- (UMLS (NCI) C0879411) =Therapeutic or Preventive Procedure
|
- 6. Do not resuscitate
- (UMLS (HL7) C1547313) =Intellectual Product =Advance Directive Code;
| - 56. Docetaxel/R101933
- (UMLS (NCI) C1134556) =Therapeutic or Preventive Procedure ;
|
- 7. Do not shake
- (UMLS (HL7) C1550123) =Idea or Concept =Special Handling Code;
| - 57. Docetaxel/Sulindac
- (UMLS (NCI) C1134670) =Therapeutic or Preventive Procedure
|
- 8. do not shake
- [Do not shake ( HL7V3.0 )] (UMLS (HL7) C1550586) =Idea or Concept =EntityHandling;
| - 58. Docetaxel/Suramin
- (UMLS (NCI) C1328022) =Therapeutic or Preventive Procedure; ;
|
- 9. Doberman
- [The Doberman Pinscher is a muscular and very powerful dog. Its hard, short-haired, close-fitting coat comes in black, black and tan, blue-gray, red, fawn and white. The hair is short, thick and tight to its body. The ears are usually cropped and then taped for a couple of months to make them stand up. If left natural the ears develop somewhat like a hound. Height: 24-28 inches (61-71 cm.) Weight: 66-88 pounds (30-40 kg.) ( NCI )] (UMLS (NCI) C0324358) =Mammal
| - 59. Docetaxel/Tamoxifen
- (UMLS (NCI) C0935785) =Therapeutic or Preventive Procedure ;
|
- 10. Dobupride
- (UMLS (NCI) C0386741) =Organic Chemical; Pharmacologic Substance ;
| - 60. Docetaxel/Tariquidar
- (UMLS (NCI) C1328077) =Therapeutic or Preventive Procedure ;
|
- 11. dobutamine
- [beta-2 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia; it is proposed as a cardiotonic after myocardial infarction or open heart surgery. ( CSP )] (UMLS (CSP) C0012963) =Organic Chemical; Pharmacologic Substance ;
=Cardioprotective Agent;
catecholamine;
Phenethylamines;
[AU100] SYMPATHOMIMETICS (ADRENERGICS) =DOBUTAMINE HYDROCHLORIDE | - 61. Docetaxel/Thalidomide
- (UMLS (NCI) C0879429) =Therapeutic or Preventive Procedure
|
- 12. DOBUTAMINE TARTRATE
- [The tartrate salt form of dobutamine, a synthetic catecholamine with sympathomimetic activity. Dobutamine primarily binds to and stimulates beta-1-adrenergic receptors located in the myocardium. As a result, it leads to a positive inotropic effect and increases in cardiac output. ( NCI )] (UMLS (NCI) C0887392) =Organic Chemical; Pharmacologic Substance ;
| - 62. Docetaxel/TLK286
- (UMLS (NCI) C1328041) =Therapeutic or Preventive Procedure ;
|
- 13. Dobutrex
- (UMLS (NCI) C0012964) =Organic Chemical; Pharmacologic Substance ;
| - 63. Docetaxel/Trastuzumab
- (UMLS (NCI) C0879507) =Therapeutic or Preventive Procedure ;
|
- 14. DOC-1R
- [Ubiquitous 126-aa 13-kDa Tumor Suppressor Deleted In Oral Cancer-Related 1 protein is encoded by human DOC-1R Gene (DOC1 Family). (NCI) ( NCI )] (UMLS (NCI) C0910618) DOC-1R Protein;
Tumor Suppressor Deleted in Oral Cancer-Related 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 64. Docetaxel/Vinorelbine
- (UMLS (NCI) C0338251) =Therapeutic or Preventive Procedure
|
- 15. Docarpamine
- (UMLS (NCI) C0075755) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 65. Docetaxel/ZD6474
- (UMLS (NCI) C1327880) =Therapeutic or Preventive Procedure ;
|
- 16. Docetaxel Anhydrous
- [The anhydrous form of docetaxel, a semisynthetic side-chain analogue of paclitaxel with antineoplastic property. Docetaxel binds specifically to the beta-tubulin subunit of microtubules and thereby antagonizes the disassembly of the microtubule proteins. This results in the persistence of aberrant microtubule structures and results in cell-cycle arrest and subsequent cell death. ( NCI )] (UMLS (NCI) C0771375) DOCETAXEL, ANHYDROUS =Organic Chemical; Pharmacologic Substance
| - 66. dociton
- [ ] (UMLS (CSP) C0700770) =Organic Chemical; Pharmacologic Substance
|
- 17. Docetaxel/DN-101
- (UMLS (NCI) C1328170) =Therapeutic or Preventive Procedure; ;
| - 67. Docking Protein 1
- [Docking Protein 1, encoded by the human DOK1 gene, interacts with receptor tyrosine kinases and mediates particular biological responses. This 62-kD protein is associated with p120 Ras-GAP and this association is correlated with its tyrosine phosphorylation. It is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr/abl), a chimeric protein whose presence is associated with CML. It plays an important role in mitogenic signaling and its aberrant phosphorylation may contribute to the progression of different human diseases. It is phosphorylated by the insulin receptor kinase, resulting in the negative regulation of the insulin signaling pathway. (From LocusLink, Swiss-Prot, OMIM and NCI) ( NCI )] (UMLS (NCI) C1333311) Docking Protein 1 (Downstream of Tyrosine Kinase 1);
Docking Protein 1, 62kD (Downstream of Tyrosine Kinase 1);
Docking Protein, 62-kD;
DOK1;
Downstream of Trosine Knase 1;
p62(DOK);
p62DOK;
pp62;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 18. Docetaxel/Doxorubicin
- (UMLS (NCI) C0392970) =Therapeutic or Preventive Procedure ;
| - 68. Docking Protein 1, 62kD (Downstream of Tyrosine Kinase 1) Gene
- [This gene plays a role in signal transduction and negative regulation of cell proliferation. ( NCI )] (UMLS (NCI) C1333246) DOK1;
DOK1 Gene;
=Gene or Genome ;
|
- 19. Docetaxel/Doxorubicin HCl Liposome
- (UMLS (NCI) C0678063) =Therapeutic or Preventive Procedure ;
| - 69. docosahexaenoic acid
- [C22-unsaturated fatty acids found predominantly in FISH OILS. ( MSH )] (UMLS (CSP) C0012968) =Lipid; Pharmacologic Substance; Biologically Active Substance =Fatty Acids, Omega-3;
Inactive Ingredient Preparations =DOCOSAHEXAENOIC ACID 120 MG/GM |
- 20. Docetaxel/Doxorubicin Hcl Liposome/Trastuzumab
- (UMLS (NCI) C0879443) =Therapeutic or Preventive Procedure ;
| - 70. Doctor
- [individual qualified by education and legally authorized to practice medicine. ( CSP )] (UMLS (NCI) C0031831) =Professional or Occupational Group ;
=health care personnel;
RoleClass =general practitioner;
primary care physician;
|
- 21. Docetaxel/Doxorubicin/Oblimersen
- (UMLS (NCI) C1327995) =Therapeutic or Preventive Procedure ;
| - 71. Doctor number
- (UMLS (HL7) C1549693) =Intellectual Product =Identifier type;
|
- 22. Docetaxel/Doxorubicin/Tamoxifen
- (UMLS (NCI) C0796522) DOX/TMX/TXT =Therapeutic or Preventive Procedure
| - 72. Doctor of Business Administration
- (UMLS (HL7) C1549964) =Intellectual Product =Degree/license/certificate;
|
- 23. Docetaxel/Epirubicin
- (UMLS (NCI) C0392962) =Therapeutic or Preventive Procedure ;
| - 73. Doctor of Education
- (UMLS (HL7) C1549965) =Intellectual Product =Degree/license/certificate;
|
- 24. Docetaxel/Epirubicin/Filgrastim
- (UMLS (NCI) C0392963) =Therapeutic or Preventive Procedure ;
| - 74. Doctor of Engineering
- (UMLS (HL7) C1549988) =Intellectual Product =Degree/license/certificate;
|
- 25. Docetaxel/Epirubicin/Pegfilgrastim
- (UMLS (NCI) C1328016) =Therapeutic or Preventive Procedure; ;
| - 75. Doctor of Medicine
- [The Doctor of Medicine degree is the first-professional postgraduate degree that requires completion of a program that meets all of the following criteria: completion of the academic requirements to begin practice in the profession; at least 2 years of college work prior to entering the program; and a total of at least 6 academic years of college work to complete a program of studies in any branch of medical science, including prior required college work plus the length of the professional program itself. The academic standard is equivalent to Ph.D. science. ( NCI )] (UMLS (HL7) C1512018) M.D.;
MD =Intellectual Product =Degree/license/certificate;
|
- 26. Docetaxel/Erlotinib
- (UMLS (NCI) C1327739) =Therapeutic or Preventive Procedure ;
| - 76. Doctor of Osteopathy
- (UMLS (HL7) C1549967) =Intellectual Product =Degree/license/certificate;
|
- 27. Docetaxel/Estramustine
- (UMLS (NCI) C0677761) =Therapeutic or Preventive Procedure
| - 77. Doctor of Philosophy
- [The Doctor of Philosophy degree is the highest academic degree awarded in recognition of creative scholarship and research in a field of study. The recipient of this degree must have demonstrated proficiency in a broad area of learning and the ability to critically evaluate work in the discipline. The degree is not awarded solely for completing a prescribed number of courses, but for having undertaken and completed independent work in the discipline leading to an original contribution to knowledge. ( NCI )] (UMLS (HL7) C1512022) Ph.D.;
PhD =Intellectual Product ;
=Degree/license/certificate;
|
- 28. Docetaxel/Estramustine/Exisulind
- (UMLS (NCI) C1327846) =Therapeutic or Preventive Procedure; ;
| - 78. Doctor of Science
- (UMLS (HL7) C1549989) =Intellectual Product =Degree/license/certificate;
|
- 29. Docetaxel/Estramustine/Hydrocortisone
- (UMLS (NCI) C0393037) =Therapeutic or Preventive Procedure
| - 79. Doctoral or post graduate education
- [Doctoral or post graduate education ( HL7V3.0 )] (UMLS (HL7) C1552037) =Idea or Concept =Education Level;
|
- 30. Docetaxel/Estramustine/Mitoxantrone/Prednisone
- (UMLS (NCI) C0796411) EM/DHAD/PRED/TXT =Therapeutic or Preventive Procedure
| - 80. Doctor_s Office Closed
- (UMLS (HL7) C1547234) =Intellectual Product =Case Category Code;
|
- 31. Docetaxel/Estramustine/Thalidomide
- (UMLS (NCI) C1134522) =Therapeutic or Preventive Procedure
| - 81. document
- [The notion of a document comes particularly from the paper world, where it corresponds to the contents recorded on discrete pieces of paper. In the electronic world, a document is a kind of composition that bears resemblance to their paper world counter-parts. Documents typically are meant to be human-readable. HL7's notion of document differs from that described in the W3C XML Recommendation, in which a document refers specifically to the contents that fall between the root element's start-tag and end-tag. Not all XML documents are HL7 documents. ( HL7V3.0 )] (UMLS (HL7) C1563337) =Idea or Concept ;
=Attestable unit;
=clinical document |
- 32. Docetaxel/Exisulind
- (UMLS (NCI) C0935886) =Therapeutic or Preventive Procedure
| - 82. Document Availability Status
- (UMLS (HL7) C1547676) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Obsolete;
Available for patient care;
Unavailable for patient care;
Deleted |
- 33. Docetaxel/Filgrastim/Gemcitabine
- (UMLS (NCI) C0935823) =Therapeutic or Preventive Procedure
| - 83. document body
- [A context that distinguishes the body of a document from the document header. This is seen, for instance, in HTML documents, which have discrete and elements. ( HL7V3.0 )] (UMLS (HL7) C1551342) =Idea or Concept ;
=organizer;
|
- 34. Docetaxel/Filgrastim/Trastuzumab/Vinorelbine
- (UMLS (NCI) C1134700) =Therapeutic or Preventive Procedure ;
| - 84. Document completion status
- (UMLS (HL7) C1547674) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Authenticated;
Incomplete;
In Progress;
Legally authenticated;
Pre-authenticated;
Documented;
Dictated;
|
- 35. Docetaxel/Filgrastim/Vinorelbine
- (UMLS (NCI) C0338252) =Therapeutic or Preventive Procedure
| - 85. Document Confidentiality Status
- (UMLS (HL7) C1547675) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Usual control;
Very restricted;
Restricted;
|
- 36. Docetaxel/Filgrastim/XR9576
- (UMLS (NCI) C0935817) =Therapeutic or Preventive Procedure
| - 86. Document response
- (UMLS (HL7) C1548021) =Idea or Concept =Message type;
|
- 37. Docetaxel/Flavopiridol
- (UMLS (NCI) C0935851) =Therapeutic or Preventive Procedure
| - 87. document section
- [A context that subdivides the body of a document. Document sections are typically used for human navigation, to give a reader a clue as to the expected content. Document sections are used to organize and provide consistency to the contents of a document body. Document sections can contain document sections and can contain entries. ( HL7V3.0 )] (UMLS (HL7) C1551341) Section;
=Idea or Concept ;
=organizer;
|
- 38. Docetaxel/Fluorouracil/Leucovorin Calcium
- (UMLS (NCI) C0935821) =Therapeutic or Preventive Procedure
| - 88. Document Storage Status
- (UMLS (HL7) C1547677) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Active and archived;
Archived (not active);
Purged;
Active |
- 39. Docetaxel/Fowlpox-PSA Vaccine
- (UMLS (NCI) C1327777) =Therapeutic or Preventive Procedure ;
| - 89. document verification
- [Verification by means of document. Example: Fax, letter, attachment to e-mail. ( HL7V3.0 )] (UMLS (HL7) C1699063) =Functional Concept =VerificationMethod;
|
- 40. Docetaxel/Fowlpox-PSA Vaccine/Sargramostim
- (UMLS (NCI) C1327852) =Therapeutic or Preventive Procedure
| - 90. DocumentCompletion
- [Identifies the current completion state of a clinical document. ( HL7V3.0 )] (UMLS (HL7) C1553806) =Intellectual Product =CodeSystem;
=Authenticated;
Incomplete;
In Progress;
Legally authenticated;
Pre-authenticated;
Documented;
Dictated;
|
- 41. Docetaxel/Gefitinib
- (UMLS (NCI) C1327979) =Therapeutic or Preventive Procedure ;
| - 91. Documented
- [A completion status in which document content, other than dictation, has been received but has not been translated into the final electronic format. Examples include paper documents, whether hand-written or typewritten, and intermediate electronic forms, such as voice to text. ( HL7V3.0 )] (UMLS (HL7) C1609436) =Idea or Concept =Document completion status;
DocumentCompletion |
- 42. Docetaxel/GEM 231
- (UMLS (NCI) C0796667) =Therapeutic or Preventive Procedure
| - 92. Documented
- [Furnished with or supported by documents and documentation. ( NCI )] (UMLS (NCI) C1301725) =Health Care Activity; ;
|
- 43. Docetaxel/Gemcitabine
- (UMLS (NCI) C0796493) TXT/dFdC;
=Therapeutic or Preventive Procedure ;
| - 93. documents
- [The source act documents the target act. ( HL7V3.0 )] (UMLS (HL7) C1548385) =Intellectual Product ;
=is sequel;
|
- 44. Docetaxel/GTI-2040
- (UMLS (NCI) C1328099) =Therapeutic or Preventive Procedure; ;
| - 94. DocumentStorage
- [Identifies the storage status of a document. ( HL7V3.0 )] (UMLS (HL7) C1553807) =Intellectual Product =CodeSystem;
=Archived (not active);
Purged;
active;
|
- 45. Docetaxel/Hypericum perforatum
- (UMLS (NCI) C1134709) =Therapeutic or Preventive Procedure ;
| - 95. DODECLONIUM BROMIDE
- (UMLS (NCI) C0771501) =Organic Chemical; Pharmacologic Substance
|
- 46. Docetaxel/Ifosfamide
- (UMLS (NCI) C1134495) =Therapeutic or Preventive Procedure
| - 96. Dodicin
- (UMLS (NCI) C0058646) =Organic Chemical; Pharmacologic Substance
|
- 47. Docetaxel/Infliximab
- (UMLS (NCI) C1134703) =Therapeutic or Preventive Procedure ;
| - 97. dog
- [refers to all members of the dog family, from all breeds of domestic dogs through wolves. ( CSP )] (UMLS (CSP) C1280551) =Mammal =Carnivora;
|
- 48. Docetaxel/Irinotecan
- (UMLS (NCI) C0796648) =Therapeutic or Preventive Procedure
| - 98. DOG BITE
- (UMLS (ICD9CM) C0259797) =Injury or Poisoning
|
- 49. Docetaxel/Ketoconazole
- (UMLS (NCI) C1134671) =Therapeutic or Preventive Procedure
| - 99. Dolasetron Mesylate
- [An indole derivative with antiemetic activity. As a selective serotonin receptor antagonist, dolasetron mesylate competitively blocks the action of serotonin at 5HT3 receptors, resulting in suppression of chemotherapy- and radiotherapy-induced nausea and vomiting. (NCI04) ( NCI )] (UMLS (NCI) C0065818) =Organic Chemical; Pharmacologic Substance =Indole;
quinolizine;
Dolasetron;
=Dolasetron 20 MG/ML;
DOLASETRON MESYLATE 100 MG;
DOLASETRON MESYLATE 12.5 MG/0.625ML;
DOLASETRON MESYLATE 50 MG |
- 50. Docetaxel/Leuprolide/Testosterone
- (UMLS (NCI) C1328057) =Therapeutic or Preventive Procedure; ;
| - 100. Dolastatin 10
- [An anticancer drug that belongs to the family of drugs called mitotic inhibitors. ( NCI )] (UMLS (NCI) C0082338) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
home
